 |
Module 3: Ethical Issues in Research on Gene-Environment Interactions |
|
|
|
Bibliography
Aardema MJ, MacGregor JT. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies. Mutation Research/ Fundamental and Molecular Mechanisms of Mutagenesis. 2002;499(1):13-25. Absher RK, Moore ME, Parker MH. Patient-specific factors predictive of warfarin dosage requirements. The Annals of Pharmacotherapy. 2002;36(10):1512-7. Anthony JC, Eaton WW, Henderson AS. Looking to the future in psychiatric epidemiology. Epidemiologic Reviews.1995;17(1):240-2. Berkowitz GS, Wolff MS, Matte T, Susser E, Landrigan PJ. The rationale for a national prospective cohort study of environmental exposure and childhood development. Environmental Research. 2001;85(2):59-68. Block GD, Aulisio MI. Will genetics revolutionize medicine? New England Journal of Medicine. 2000;343(20):1496. Burke W, Coughlin SS, Lee NC, Weed DL, Khoury MJ. Application of population screening principles to genetic screening for adult-onset conditions. Genetic Testing. 2001;5(3):201-11. Childress JF, Faden RR, Gaare RD, et al. Public health ethics: mapping the terrain. Journal of Law, Medicine & Ethics. 2002;30(2):170-8. Christiani DC, Sharp RR, Collman GW, Suk WA. Applying genomic technologies in environmental health research: challenges and opportunities. Journal of Occupational and Environmental Medicine. 2001;43(6):526-33. Clayton EW. Genetics, public health, and the law. In: Khoury MJ, Burke W and Thomson E, eds. Genetics and public health in the 21st century: Using genetic information to improve health and prevent disease. New York, NY: Oxford University Press; 2000: 489-502. Cooper RS. Gene-environment interactions and the etiology of common complex disease. Annals of Internal Medicine. 2003;139(5 Pt 2):437-40. Cooper RS, Kaufman JS, Ward R. Race and genomics. New England Journal of Medicine. 2003;348(12):1166-70. DeCamp M, Sugarman J. Ethics in population-based genetic research. Accountability in Research. 2004; 11: 1-26. DeCamp M, Sugarman J. Ethics in behavioral genetics research. Accountability in Research. 2004; 11: 27-47. DeCamp M, Sugarman J. Ethics and research assessing the relative roles of genes and the environment. Accountability in Research. 2004; in press. Eaton W. The logic for a conception-to-death cohort study. Annals of Epidemiology. 2002;12(7):445-51. Ference BA, Chauhan MS, Izumo S. Will genetics revolutionize medicine? New England Journal of Medicine. 2000;343(20):1497-8. Foster MW, Sharp RR. Race, ethnicity, and genomics: social classifications as proxies of biological heterogeneity. Genome Research. 2002;12(6):844-50. Gerard S, Hayes M, Rothstein MA. On the edge of tomorrow: fitting genomics into public health policy. Journal of Law, Medicine & Ethics. 2002;30(3 Suppl):173-6. Gorlova OY, Amos C, Henschke C, Lei L, et al. Genetic susceptibility for lung cancer: interactions with gender and smoking history and impact on early detection policies. Human Heredity: International Journal of Human and Medical Genetics. 2003;56(1-3):139-45. Holden C. Race and medicine. Science. 2003;302(5645):594-6. Holtzman N. Is public health ready for genetics? Archives of Pediatrics & Adolescent Medicine. 2001;155(2):117-8. Holtzman NA. Expanding newborn screening: how good is the evidence? Journal of the American Medical Association. 2003;290(19):2606-8. Holtzman NA, Marteau TM. Will genetics revolutionize medicine? New England Journal of Medicine. 2000;343(2):141-4. Institute of Medicine Committee for the Study of the Future of Public Health. The Future of Public Health. Washington, D.C.: National Academy Press; 1988. Jansson R, Watts C, Katz A, et al. Genetic testing in the workplace: Implications for public policy: Available at: http://depts.washington.edu/phgen/PilotProjects/Genetic%20Testing%20in%20the%20Workplace.PDF. 2000;Accessed November 2003. Johnson A. The genetic key to public health. State Legislatures. 2003;29(2):28-30. Kahn J. Getting the numbers right: statistical mischief and racial profiling in heart failure research. Perspectives in Biology and Medicine. 2003;46(4):473 – 83. Kaplan JB, Bennett T. Use of race and ethnicity in biomedical publication. Journal of the American Medical Association. 2003;289(20):2709-2716. Kass NE. An ethics framework for public health. American Journal of Public Health. 2001;91(11):1776-82. Kaufman JS, Cooper RS. Commentary: considerations for use of racial/ethnic classification in etiologic research. American Journal of Epidemiology. 2001;154 (4):291-298. Kelada SN, Eaton DL, Wang SS, Rothman NR, Khoury, MJ. The role of genetic polymorphisms in environmental health. Environmental Health Perspectives. 2003;111(8):1055-64. Khoury MJ. From genes to public health: The applications of genetic technology in disease prevention. Genetics Working Group. American Journal of Public Health. 1996;86(12):1717-22. Khoury MJ. Will genetics revolutionize medicine? New England Journal of Medicine. 2000;343(20):1497;discussion 1498. Khoury MJ, Burke W, Thomson E. Genetics and public health: a framework for the integration of human genetics into public health. In: Khoury MJ, Burke W and Thomson E, eds. Genetics and public health in the 21st century: Using genetic information to improve health and prevent disease. New York, NY: Oxford University Press; 2000. Langheier JM, Snyderman R. Prospective medicine: the role for genomics in personalized health planning. Pharmacogenomics. 2004;5(1):1-8. Lash LH, Hines RN, Gonzalez FJ, Zacharewski TR, Rothstein MA. Genetics and susceptibility to toxic chemicals: do you (or should you) know your genetic profile? Journal of Pharmacology and Experimental Therapeutics. 2003;305(2):403-9. Lindpaintner K. Pharmacogenetics and the future of medical practice. Journal of Molecular Medicine. 2003;81(3):141-53. Little J, Khoury MJ, Bradley L, et al. The human genome project is complete. How do we develop a handle for the pump? American Journal of Epidemiology. 2003;157(8):667-73. MacQueen KM, Karim QA, Sugarman J. Ethics guidance for HIV prevention trials. British Medical Journal. 2003;327(7410):340. Marchant GE. Toxicogenomics and toxic torts. Trends in Biotechnology. 2002;20(8):329-32. McBride CM, Bepler G, Lipkus IM, et al. Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiology, Biomarkers & Prevention. 2002;11(6):521-8. Merikangas KR, Risch N. Genomic priorities and public health. Science. 2003;302(5645):599-601. National Institute of Environmental Health Sciences. Environmental Genome Project Homepage. Available at: http://www.niehs.nih.gov/envgenom/home.htm. Accessed May 2004. Omenn GS. Public health genetics: an emerging interdisciplinary field for the post-genomic era. Annual Review of Public Health. 2000;21:1-13. Omenn GS. Genetics and public health: Historical perspectives and current challenges and opportunities. In: Khoury MJ, Burke W and Thomson E, eds. Genetics and public health in the 21st century: Using genetic information to improve health and prevent disease. New York, NY: Oxford University Press; 2000: 25-44. Omenn GS. The crucial role of the public health sciences in the postgenomic era. Genetic Medicine. 2002;4(6 Suppl):21S-26S. Pesonen LM. Genetic screening: an employer's tool to differentiate or to discriminate? Journal of Contemporary Health Law & Policy. 2002;19(1):187-223. Risch N, Burchard E, Ziv E, Tang H. Categorization of humans in biomedical research: genes, race and disease. Genome Biology. 2002;3(7):comment2007. Rothstein MA. Rethinking the meaning of public health. Journal of Law, Medicine & Ethics. 2002;30(2):144-9. Rothstein, MA, ed. Pharmacogenomics: Social, ethical, and clinical dimensions. Hoboken, NJ: Wiley-Liss, 2003. Rothstein MA, Epps PG. Ethical and legal implications of pharmacogenomics. Nature Reviews Genetics. 2001;2(3):228-31. Sharp RR, Barrett JC. The Environmental Genome Project and bioethics. Kennedy Institute of Ethics Journal. 1999;9(2):175-88. Shields PG, Harris CC. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. Journal of Clinical Oncology. 2000;18(11):2309-15. Sotos, JG and Rienhoff, HY, Jr. Will genetics revolutionize medicine? New England Journal of Medicine. 2000;343(20):1496;discussion 1498. Susser E, Terry MB. A conception-to-death cohort. Lancet. 2003;361(9360):797-8. Swallen KC. Race and genomics. New England Journal of Medicine. 2003;348(25):2581-2;author reply 2581-2. Swan GE. Implications of genetic epidemiology for the prevention of tobacco use. Nicotine & Tobacco Research. 1999;1(Suppl 1):S49-56. Swan GE, Hudmon KS, Jack LM, et al. Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation. Cancer Epidemiology, Biomarkers & Prevention. 2003;12(10):994-1005. Wicks AC, Sever LE, Harty R, Gajewski SW, Marcus-Smith M. Screening workers for genetic hypersusceptibility: potential ethical, legal, and social implications from the human genome project. Journal of Health and Human Services Administration. 1999;22(1):116-32. Williams SM, Templeton AR. Race and genomics. New England Journal of Medicine. 2003;348(25):2581-2.
The materials on this site and in each module are copyrighted by Duke University and Johns Hopkins University and may not be copied, transmitted, or published without explicit written permission. © 2004 Duke Universtiy Medical Center and Johns Hopkins University. Site Design by MediSpin, Inc. Site hosting by Duke Educational Media Services |